Intravenous Iron in Palliative Care

Slides:



Advertisements
Similar presentations
1 Hypochromic Microcytic Anaemias in Children Mariane de Montalembert, MD Service de Pédiatrie Hospital Necker Paris, France Adlette C. Inati, MD Head.
Advertisements

Unexplained Anaemia Acute Medicine Update
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
Neel Bhalala (2009) Sofia Medical University. Background  Erythropoiesis-stimulating agents are man-made versions of a natural protein known as erythropoietin.
Intravenous Iron Supplementation and Chronic Kidney Disease Chloe Bierbower December 2, 2013.
Acute Oncology Service (Insert relevant service name)
Introduction to Haematology! Elliot Catchpole PCMD Starting with anaemias!
ESMO 2011 Lung Cancer AVAPERL Study Authors: Dr. Sunil Verma Date posted: September 28 th, 2011.
25-OH Vitamin D Levels in a Community Based Primary Care Office in Western New York By Ryan Weber D.O.
Chemotherapy Audit  Audit of patients who died within three months of their last dose of chemotherapy at Airedale General Hospital  The records of 50.
Dr. Mohamed M. Ghanem. Definition A deficiency in iron results in the development of anemia (lower than normal number of red blood cells). In iron deficiency.
CD-1 Second-line Chemotherapy for Hormone Refractory Prostate Cancer Disease Background Nicholas J. Vogelzang, MD Director Nevada Cancer Institute CD-1.
TREATMENT IRON DEFICIENCY ANEMIA. 3 Approaches in the Treatment of IDA: 1.Red Cell Transfusion 2.Oral Iron Therapy 3.Parenteral Iron Therapy Braunwald.
By Amber Masso Program Director American Childhood Cancer Organization Having Fun and Helping a Cause: An Introduction to Childhood Cancer for Students.
CON - 1 Conclusions C David R. Parkinson Vice President, Global Head, Clinical Research and Development Novartis Pharmaceuticals Corporation.
Iron as a Treatment: Successes and Failures. What next? Christopher J Earley MB, BCh, PhD, FRCP(I) Professor Department of Neurology Johns Hopkins School.
The use of Ferinject® (ferric carboxymaltase) in the treatment of iron deficiency in patients with renal anaemia Dr D Farrugia Dr S Ramakrishna E Gibson.
Aetiology of preoperative anaemia in patients undergoing elective cardiac surgery Jacob Abhrahm 1,Romi Sinha 2,Kathryn Robinson 3, David Cardone 1 1 Department.
Context and Problem At a national level 65% of all staff in GP practices completed the survey. LHB’s took different approaches to encouraging uptake, with.
AF in the West Midlands: Prevalence, pathways and management Dr Indira Natarajan FRCP, Clinical Director for Stroke, West Midlands SCN & Senate Dr Orsolina.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
FIT Programme (Faecal Immunohistochemical Test)
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
Medical Directorate, National Kidney Foundation, Singapore
Cost conscious project: Microcytic anemia
Brain imaging prior to lung cancer resection
Dr Dylan Harris Dr Mel Jefferson
Home healthcare – an economic choice for the Health Service?
Patient’s experiences of anticancer therapy and opportunities for community pharmacists to support patients with cancer. Fiona MacLean1, Alexander Mullen2,
Uttam M Chouhan Pharmacist Glan Clwyd Hospital, BCUHB September 2017
Mansoura International Hospital Mansoura International Hospital
Right Care Deep Dives NEW Devon CCG Blood Disorders.
Dr. Rebecca Croft SpR Palliative Medicine.
Brain imaging prior to lung cancer resection
Telepsychiatry: Cost Effective Solution to Integrated Care
Lenograstim Chemical Formula : C840-H1330-N222-O242-S8
Improved diagnosis, therapy and outcomes for patients with CUP
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Dr Alison Giles Palliative Medicine Consultant
Figure 1. Overall survival of patients receiving alternative medicine (solid lines) vs conventional cancer treatment (dashed lines). Overall survival of.
Junliang Liu, M.D., M.Sc. Ph.D., FRCPC Assistant Professor
What Are Clinical Trials?
Iv iron and your heart operation
QIP: Intravenous Iron Service for Renal Anaemia at SaTH
Audit of Provision of Home Intravenous Chemotherapy to Children With Acute Lymphoblastic Leukaemia. Deirdre Armstrong Paediatric Macmillan Nurse Specialist.
Primary-Secondary Care Partnership in Treatment of Severe Cellulitis
Chapter 2: Clinical Indicators and Preventive Care
Disclaimer: This presentation has been designed for UK Healthcare Trusts using guidelines available by February If you wish to use this presentation.
How do we delay disease progress once it has started?
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB.
Local networking sessions
Rossi A et al. Proc ASCO 2011;Abstract 8008.
Kantarjian H et al. Cancer 2009;[Epub ahead of print].
“seen very quickly from referral. understanding practitioner “
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Volume 2: End-Stage Renal Disease
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Evidence-based Medicine Curriculum
Liverpool Heart and Chest Hospital
LEARNER VOICE AND QUALITY ASSURANCE IN WALES
2017 National Cancer Patient Experience Survey Overview of NBT Results Published September 2018 Carol Chapman Lead Cancer Nurse Patient Experience Group.
Overview of assessment approach
Dr. Rasha Salama PhD Community Medicine Suez Canal University Egypt
Identifying Low-Risk Patients with Pulmonary Embolism Suitable For Outpatient Treatment A VERITY Registry Pilot Study N Scriven, T Farren, S Bacon, T.
A single centre experience of febrile neutropenia rates in long acting compared with short acting GCSF preparations in breast cancer patients Dr Rebecca.
Approach to anemia.
Stroke Protocols Ensure Efficient Patient Intake, Diagnosis, Treatment
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
The fingerprint of SWIMMING in Wales
Presentation transcript:

Intravenous Iron in Palliative Care Dr Wynitia Jones F2 Y Bwythyn Newydd, Bridgend

Content Introduction Methods Results Discussion Questions

Introduction Anaemia is common and multifactorial Blood transfusions are widely used A proportion of patients will present with iron deficiency anaemia Could iron infusions be a transfusion alternative?

Cost £147.50 for 1 unit £7.97 per 2mL amp (100mg)

Methods Literature search Case-note review of the last 20 patients who had blood transfusions establish how many had an iron-deficient picture Telephone survey across Wales how many are offering iron infusions Forums

Results: Case-note Review 20 notes reviewed 8 still alive 12 deceased Mean survival: 4.5 months Median survival: 4 months Range: 1 – 19 months IV Iron raises Hb by 1-2grams/week i.e. patients are surviving long enough to feel the benefits of IV iron

Breakdown of the FBC

Patients with Microcytic Anaemia Primaries: breast, colon, lung, prostate 3 = cancer related 1 = chemo related 2 did not require subsequent transfusions

Results: Telephone Survey 9 Inpatient units 3 oupatient units 2 community based units 11 units offered a blood transfusion service Very little use of IV iron across Wales

Results: Literature Search Improved side effect profile for low molecular weight iron dextran Lots of evidence for patients who are receiving erythropoeitic-stimulating agents having chemo I was unable to find evidence for our subset of patients

Results: Forums Dr Dean Blackburn “……the drive locally is very much to identify and treat all those with iron deficiency as a way of reducing overall blood requirements” ”Ferinject is a new one off treatment for Iron Deficiency (Not needing 6 or more doses like Venofer). No anaphylaxis potential, significantly more expensive but much cheaper than blood.” 

Diagnosis of Anaemia Identify iron deficient patients Microcytic indices are not diagnostic Normally comment on serum ferritin Consider looking at the total iron binding capacity

Evaluation Strengths Weaknesses Extensive literature search Limited number of patients assessed Established an impression of practice throughout Wales Telephone survey results difficult to interpret Used a range of sources New communications that need follow up

Discussion Very small population of patients Is this too small to change practice? Careful diagnosis is required Slower to raise Hb – may require a change in follow up

Potential to be cost effective Improved side effect profile Reduce the number of day hospital attendances Used elsewhere successfully

Thank you for listening! Any questions? Thank you for listening!